Novel therapy may eradicate lung cancer
30 Oct 2009, 1244 Hrs

Add comment          Mail          Print          Write to Editor

Washington, Oct 30 Scientists from UT Southwestern Medical Center have suggested a novel therapeutic strategy that would completely eradicate lung cancer.

Researchers Pier Paolo Scaglioni and Georgia Konstantinidou have shown that using an investigative drug called BEZ235 in combination with low-dose radiation successfully eliminated non-small cell lung (NSCL) cancer in mice.

"These early results suggest that the drug-radiation combination might be an effective therapy in lung cancer patients," said Dr. Scaglioni.

NSCL cancer cells often harbor mutations in a gene called K-RAS. Patients with such K-RAS mutations typically are more resistant to treatment with radiation and have a poor prognosis.

K-RAS mutations lead to the activation of networks, or pathways, of several so-called signaling proteins, which in turn play key roles in the regulation of tumor growth. One of these proteins, called PI3K, is activated to keep cells alive that have sustained DNA damage.

Several components of the signaling pathways, including PI3K, have been investigated as possible anti-cancer drug targets. The investigational drug BEZ235 is currently being tested in clinical trials against PI3K and another signaling protein called mTOR. To date, no effective targeted therapy exists for NSCL cancer tumors that harbor K-RAS mutations," said Scaglioni.

During the study, researchers exposed isolated cancer cells to BEZ235 followed by low doses of radiation, which induced small breaks in the DNA of the cells but otherwise would have no effect on cell survival. When this type of DNA damage occurs, cancer cells rely on the PI3K signaling pathway to survive while they repair their DNA.

"We stressed the cells in such a way that they needed this signaling pathway to survive. Without the PI3K response, they will die," said Scaglioni.

When the researchers treated the cells with BEZ235, which blocks PI3K, the stressed NSCL cancer cells readily underwent programmed cell death. (ANI)

Related Latest

Four in 10 'coma patients' may be conscious, says expert Brooding Gattuso may consider a farewell to AC Milan Gago and Van Nistelrooy may leave Real Madrid One in four 'coma patients' may be conscious, says expert Malaysian government may allow parents to cane children Rofecoxib's adverse heart effects may have been identified years earlier 'Unimpressed' PCB may sack ageing Alam after Kiwi tour Surgery may reverse type 2 diabetes in morbidly obese people Global warming may be unstoppable, says scientist Surgery may reverse type 2 diabetes in morbidly obese people

Related Latest

Was never involved in Babri, Vaghela says on Liberhan indictment Satyam scam is of over Rs.14,000 crore: CBI Protesting teachers baton charged in Lucknow Kalyan calls Liberhan report 'politically motivated' Top players for Crompton Greaves golf from Mon 25 Four in 10 'coma patients' may be conscious, says expert Welcome ceremony for Manmohan Singh shifted indoors due to rain Saints convention to decide future of Ram temple issue: Togadia Security beefed up in Jharkhand for first phase of State Assembly polls Pakistan wants to push maximum terrorists inside India: Army chief

• Was never involved in Babri, Vaghela says on Liberhan indictment
• Satyam scam is of over Rs.14,000 crore: CBI
• Protesting teachers baton charged in Lucknow
• Kalyan calls Liberhan report 'politically motivated'
• Security beefed up in Jharkhand for first phase of State Assembly polls

• भारतीय क्रिकेट की मजबूत दीवार
• कंगारूओं के आगे ढेर, चीतों से कैसे मुकाबला करेंगें शेर
• Reducing greenhouse gases may not be enough to slow global warming
• बीकानेर महापौर चुनावः एक विश्लेषण
• Deepawali: The Festival Of Lights